Y200-2087 Screening compound: 3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide

Y200-2087 Screening compound: 3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide
Y200-2087 Screening compound: 3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-2087
3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-2087

Molecular Formula

C19H13ClFN3OS (C19 H13 ClFN3 OS)

Compound Name

3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide

IUPAC name

3-chloro-N-{1-[(4-fluorophenyl)methyl]-1H-pyrazol-3-yl}-1-benzothiophene-2-carboxamide

SMILES

O=C(c(sc1c2cccc1)c2Cl)Nc1nn(Cc(cc2)ccc2F)cc1

InChI

InChI=1S/C19H13ClFN3OS/c20-17-14-3-1-2-4-15(14)26-18(17)19(25)22-16-9-10-24(23-16)11-12-5-7-13(21)8-6-12/h1-10H,11H2,(H,22,23,25)

InChI Key

KVYYQBNOUUQBES-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03072703

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.85

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.735

Distribution Coefficient, logD

4.692

Water Solubility, LogSw

-4.92

Polar Surface Area

39.032

Acid Dissociation Constant (pKa)

8.38

Base Dissociation Constant (pKb)

-0.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.30

Y200-2087 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Proteases
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y200-2087 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-2087?
Check Price and Availability of Y200-2087, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-2087 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-2087
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-2087
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-2087 available by request